NCT02067949View on ClinicalTrials.gov

Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient

PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

March 31, 2015

Conditions

Critical Illness

Interventions

DRUG

Simvastatin

single oral tablet 40 mg / day If the patient is able to swallow; the tablet will be given orally. Otherwise, it will be crushed, suspended in water and administered via any existing enteral feeding or gastric drainage tube

Trial Locations (1)

11361

Ain shams university hospital and cairo university hospital, Cairo

All Listed Sponsors

lead

sara mostafa amin eladawy

OTHER

NCT02067949 - Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient | Biotech Hunter | Biotech Hunter